| Primary |
| Hypertension |
23.2% |
| Drug Use For Unknown Indication |
17.0% |
| Product Used For Unknown Indication |
9.2% |
| Suicide Attempt |
9.0% |
| Cardiac Failure |
8.7% |
| Cardiac Failure Congestive |
4.5% |
| Atrial Fibrillation |
3.9% |
| Type 2 Diabetes Mellitus |
3.5% |
| Essential Hypertension |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Oedema |
2.1% |
| Hypokalaemia |
2.0% |
| Rheumatoid Arthritis |
2.0% |
| Aortic Valve Replacement |
1.8% |
| Pain |
1.7% |
| Oedema Peripheral |
1.6% |
| Hepatitis C |
1.5% |
| Prophylaxis |
1.5% |
| Coronary Artery Disease |
1.2% |
| Thrombosis Prophylaxis |
1.2% |
|
| Renal Failure Acute |
15.9% |
| Thrombocytopenia |
8.6% |
| Vomiting |
6.6% |
| Renal Failure |
6.0% |
| Death |
5.3% |
| Hyponatraemia |
5.3% |
| Weight Decreased |
5.3% |
| Weight Increased |
5.3% |
| Pancreatitis Acute |
4.6% |
| Syncope |
4.6% |
| Hypotension |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Renal Failure Chronic |
4.0% |
| Drug Interaction |
3.3% |
| Pneumonia |
3.3% |
| Toxic Epidermal Necrolysis |
3.3% |
| Hypokalaemia |
2.6% |
| Pancytopenia |
2.6% |
| Pruritus |
2.6% |
| Therapeutic Agent Toxicity |
2.6% |
|
| Secondary |
| Hypertension |
27.7% |
| Drug Use For Unknown Indication |
20.5% |
| Product Used For Unknown Indication |
13.3% |
| Diabetes Mellitus |
4.7% |
| Cardiac Failure |
3.9% |
| Atrial Fibrillation |
3.5% |
| Type 2 Diabetes Mellitus |
3.4% |
| Pain |
3.3% |
| Glomerulonephritis Membranous |
2.5% |
| Coronary Artery Disease |
1.9% |
| Thrombosis Prophylaxis |
1.8% |
| Aortic Valve Replacement |
1.7% |
| Prophylaxis |
1.7% |
| Sepsis |
1.6% |
| Accidental Exposure |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.5% |
| Essential Hypertension |
1.5% |
| Hyperlipidaemia |
1.3% |
| Myocardial Ischaemia |
1.2% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.2% |
|
| Renal Failure Acute |
17.7% |
| Vomiting |
11.4% |
| Urine Colour Abnormal |
10.4% |
| Syncope |
8.2% |
| Completed Suicide |
4.7% |
| Fallot's Tetralogy |
4.7% |
| Hypotension |
4.1% |
| Cutaneous Lupus Erythematosus |
3.8% |
| Small Intestinal Perforation |
3.5% |
| Fall |
3.2% |
| Renal Failure |
3.2% |
| Renal Failure Chronic |
3.2% |
| Blood Urea Increased |
2.8% |
| Deep Vein Thrombosis |
2.8% |
| Pancreatitis Acute |
2.8% |
| Suicide Attempt |
2.8% |
| Transaminases Increased |
2.8% |
| Atrial Fibrillation |
2.5% |
| Dehydration |
2.5% |
| International Normalised Ratio Increased |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.9% |
| Drug Use For Unknown Indication |
18.1% |
| Hypertension |
17.0% |
| Diabetes Mellitus |
4.4% |
| Atrial Fibrillation |
4.0% |
| Cardiac Failure |
3.4% |
| Prophylaxis |
3.3% |
| Rheumatoid Arthritis |
3.1% |
| Pain |
2.8% |
| Type 2 Diabetes Mellitus |
2.8% |
| Coronary Artery Disease |
2.7% |
| Pulmonary Arterial Hypertension |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.3% |
| Oedema |
1.7% |
| Osteoporosis |
1.5% |
| Hyperlipidaemia |
1.4% |
| Depression |
1.4% |
| Cardiac Failure Congestive |
1.4% |
| Multiple Myeloma |
1.3% |
| Cardiac Failure Chronic |
1.1% |
|
| Vomiting |
10.6% |
| Death |
7.5% |
| Renal Failure Acute |
6.3% |
| Pneumonia |
6.2% |
| Renal Failure |
6.2% |
| Weight Increased |
5.7% |
| Weight Decreased |
5.3% |
| Cardiac Failure |
5.3% |
| Syncope |
5.2% |
| Urinary Tract Infection |
4.4% |
| Sepsis |
4.2% |
| Hyperuricaemia |
4.0% |
| Thrombocytopenia |
4.0% |
| Oedema Peripheral |
3.9% |
| Somnolence |
3.9% |
| Drug Interaction |
3.7% |
| Myocardial Infarction |
3.7% |
| Pyrexia |
3.4% |
| Nausea |
3.3% |
| Dyspnoea |
3.1% |
|
| Interacting |
| Product Used For Unknown Indication |
34.0% |
| Hypertension |
15.8% |
| Pain |
7.2% |
| Anaesthesia |
4.6% |
| Cardiac Failure |
4.4% |
| Drug Use For Unknown Indication |
4.3% |
| Coronary Artery Disease |
3.7% |
| Restless Legs Syndrome |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Asthma |
2.3% |
| Renal Osteodystrophy |
2.3% |
| Hyperlipidaemia |
2.2% |
| Essential Hypertension |
2.0% |
| Atrial Fibrillation |
1.9% |
| Cardiac Failure Congestive |
1.6% |
| Hypertensive Heart Disease |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Bronchial Carcinoma |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.1% |
|
| Drug Interaction |
21.7% |
| Renal Failure Acute |
17.4% |
| Disorientation |
6.5% |
| Fall |
4.3% |
| Hypokalaemia |
4.3% |
| Hypotension |
4.3% |
| Infectious Peritonitis |
4.3% |
| Metabolic Alkalosis |
4.3% |
| Peritonitis |
4.3% |
| Somnolence |
4.3% |
| Dehydration |
3.3% |
| Pancytopenia |
3.3% |
| Blood Sodium Decreased |
2.2% |
| Dizziness Postural |
2.2% |
| Drug Intolerance |
2.2% |
| Hyponatraemia |
2.2% |
| Thrombocytopenia |
2.2% |
| Tubulointerstitial Nephritis |
2.2% |
| Vertigo |
2.2% |
| Vomiting |
2.2% |
|
